title: Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial.
authors.forename: D
authors.initials: D
authors.lastname: Waters
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000097:blood / Q000628:therapy*; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D009204:Myocardial Revascularization; D011758:Pyrroles / Q000627:therapeutic use*
chemical_list: D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D002784:Cholesterol; D000069059:Atorvastatin